[1]
|
Sung, H., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[2]
|
Stanley, K. and Stjernsward, J. (1989) Lung Cancer—A Worldwide Health Problem. Chest, 96, 1S-5S.
https://doi.org/10.1378/chest.96.1_Supplement.1S
|
[3]
|
Zheng, R., et al. (2022) Cancer Incidence and Mortality in China, 2016. Journal of the National Cancer Center, 2, 1-9.
https://doi.org/10.1016/j.jncc.2022.02.002
|
[4]
|
国家卫生健康委办公厅. 原发性肺癌诊疗指南(2022年版) [J]. 协和医学杂志, 2022, 13(4): 549-570.
|
[5]
|
毕磊, 等. 电视胸腔镜肺叶切除术治疗老年周围型非小细胞肺癌的疗效[J]. 医学信息, 2021, 34(7): 6-9+14.
|
[6]
|
Paz-Ares, L., et al. (2019) LBA3 Nivolumab (NIVO) + Platinum-Doublet Chemotherapy (Chemo) vs Chemo as First-Line (1L) Treatment (tx) for Advanced Non-Small Cell Lung Cancer (aNSCLC): CheckMate 227—Part 2 Final Analysis. Annals of Oncology, 30, xi67-xi68. https://doi.org/10.1093/annonc/mdz453.004
|
[7]
|
Handa, Y., et al. (2019) Surgical Outcomes of Complex versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery, 107, 1032-1039. https://doi.org/10.1016/j.athoracsur.2018.11.018
|
[8]
|
Ginsberg, R.J. and Rubinstein, L.V. (1995) Randomized Trial of Lobectomy versus Limited Resection for T1 N0 Non-Small Cell Lung Cancer. Lung Cancer Study Group. The Annals of Thoracic Surgery, 60, 615-622.
https://doi.org/10.1016/0003-4975(95)00537-U
|
[9]
|
王艳菊, 等. 高分辨薄层CT在早期肺腺癌诊断筛查中的应用价值[J]. 临床与病理杂志, 2021, 41(3): 549-553.
|
[10]
|
申江峰, 等. 三维重建指导下解剖性肺段切除43例分析[J]. 中国现代医生, 2020, 58(13): 57-59, 71, 封3页.
|
[11]
|
Saji, H., Okada, M., et al. (2022) Segmentectomy versus Lobectomy in Small-Sized Peripheral Non-Small-Cell Lung Cancer (JCOG0802/WJOG4607L): A Multicentre, Open-Label, Phase 3, Randomised, Controlled, Non-Inferiority Trial. The Lancet, 399, 1607-1617. https://doi.org/10.1016/S0140-6736(21)02333-3
|
[12]
|
Suzuki, K., et al. (2022) A Single-Arm Study of Sublobar Resection for Ground-Glass Opacity Dominant Peripheral Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery, 163, 289-301.e2.
https://doi.org/10.1016/j.jtcvs.2020.09.146
|
[13]
|
中华医学会肿瘤学分会与中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2022版) [J]. 中华肿瘤杂志, 2022, 44(6): 457-490.
|
[14]
|
Rd, N., et al. (2019) Lung Cancer. BMJ (Clinical Research ed.), 365, l1725. https://doi.org/10.1136/bmj.l1725
|
[15]
|
Ellis, P.M. and Vandermeer, R. (2011) Delays in the Diagnosis of Lung Cancer. Journal of Thoracic Disease, 3, 183-188.
|
[16]
|
Henschke, C.I., et al. (1999) Early Lung Cancer Action Project: Overall Design and Findings from Baseline Screening. The Lancet, 354, 99-105. https://doi.org/10.1016/S0140-6736(99)06093-6
|
[17]
|
Henschke, C.I., et al. (2001) Early Lung Cancer Action Project: Initial Findings on Repeat Screenings. Cancer, 92, 153-159. https://doi.org/10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S
|
[18]
|
赵殿辉, 庄悦新. HRCT诊断周围型小肺癌的价值[J]. 滨州医学院学报, 1998(1): 19-20.
|
[19]
|
王宪. 高分辨CT在肺腺癌诊断中的应用分析[J]. 世界复合医学, 2022, 8(3): 49-52.
|
[20]
|
Nakazawa, S., et al. (2018) VATS Segmentectomy: Past, Present, and Future. General Thoracic and Cardiovascular Surgery, 66, 81-90. https://doi.org/10.1007/s11748-017-0878-6
|
[21]
|
Cao, C., et al. (2015) Could Less Be More?—A Systematic Re-view and Meta-Analysis of Sublobar Resections versus Lobectomy for Non-Small Cell Lung Cancer According to Pa-tient Selection. Lung Cancer, 89, 121-132.
https://doi.org/10.1016/j.lungcan.2015.05.010
|
[22]
|
Bedat, B., et al. (2019) Comparison of Postoperative Compli-cations between Segmentectomy and Lobectomy by Video-Assisted Thoracic Surgery: A Multicenter Study. Journal of Cardiothoracic Surgery, 14, 189.
https://doi.org/10.1186/s13019-019-1021-9
|
[23]
|
Blasberg, J.D., Pass, H.I. and Donington, J.S. (2010) Sublobar Resection: A Movement from the Lung Cancer Study Group. Journal of Thoracic Oncology, 5, 1583-1593. https://doi.org/10.1097/JTO.0b013e3181e77604
|
[24]
|
Zhong, C., et al. (2012) Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer. The Annals of Thoracic Surgery, 94, 362-367. https://doi.org/10.1016/j.athoracsur.2012.04.047
|
[25]
|
Lin, Y., et al. (2016) Comparison of Treatment Outcomes between Single-Port Video-Assisted Thoracoscopic Anatomic Segmentectomy and Lobectomy for Non-Small Cell Lung Cancer of Early-Stage: A Retrospective Observational Study. Journal of Thoracic Disease, 8, 1290-1296. https://doi.org/10.21037/jtd.2016.04.65
|
[26]
|
Zhao, X., et al. (2013) Segmentectomy as a Safe and Equally Effective Surgical Option under Complete Video-Assisted Thoracic Surgery for Patients of Stage I Non-Small Cell Lung Cancer. Journal of Cardiothoracic Surgery, 8, 116. https://doi.org/10.1186/1749-8090-8-116
|
[27]
|
Molina, J.R., et al. (2008) Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clinic Proceedings, 83, 584-594. https://doi.org/10.1016/S0025-6196(11)60735-0
|
[28]
|
Winton, T., et al. (2005) Vinorelbine plus Cisplatin vs. Observation in Resected Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 352, 2589-2597. https://doi.org/10.1056/NEJMoa043623
|
[29]
|
Pignon, J.P., et al. (2008) Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group. Journal of Clinical Oncology, 26, 3552-3559. https://doi.org/10.1200/JCO.2007.13.9030
|
[30]
|
Arriagada, R., Dunant, A., et al. (2004) Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non-Small-Cell Lung Cancer. The New England Journal of Medicine, 350, 351-360.
https://doi.org/10.1056/NEJMoa031644
|
[31]
|
Cloughesy, T.F., et al. (2019) Neoadjuvant Anti-PD-1 Immuno-therapy Promotes a Survival Benefit with Intratumoral and Systemic Immune Responses in Recurrent Glioblastoma. Nature Medicine, 25, 477-486.
https://doi.org/10.1038/s41591-018-0337-7
|
[32]
|
Forde, P.M., et al. (2022) Neoadjuvant Nivolumab plus Chemo-therapy in Resectable Lung Cancer. The New England Journal of Medicine, 386, 1973-1985. https://doi.org/10.1056/NEJMoa2202170
|
[33]
|
Alifu, N., et al. (2022) Correction to “Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy”. ACS Nano, 16, 9961-9961. https://doi.org/10.1021/acsnano.2c04138
|